Other Viruses Citation List: May 22 - June 4, 2015
Hepatitis C Virus
1. Discovery of the 2-Phenyl-4,5,6,7-tetrahydro-1H-indole as a Novel anti-Hepatitis C Virus Targeting Scaffold. Andreev, I.A., D. Manvar, M.L. Barreca, D.S. Belov, A. Basu, N.L. Sweeney, N.K. Ratmanova, E.R. Lukyanenko, G. Manfroni, V. Cecchetti, D.N. Frick, A. Altieri, N. Kaushik-Basu, and A.V. Kurkin. European Journal of Medicinal Chemistry, 2015. 96: p. 250-258. PMID[25890075].
[PubMed]. OV_0522-060415.
2. Encoded Library Technology Screening of Hepatitis C Virus NS4B Yields a Small-molecule Compound Series with in Vitro Replicon Activity. Arico-Muendel, C., Z. Zhu, H. Dickson, D. Parks, J. Keicher, J. Deng, L. Aquilani, F. Coppo, T. Graybill, K. Lind, A. Peat, and M. Thomson. Antimicrobial Agents and Chemotherapy, 2015. 59(6): p. 3450-3459. PMID[25824229].
[PubMed]. OV_0522-060415.
3. The Kinase-inhibitor Sorafenib Inhibits Multiple Steps of the Hepatitis C Virus Infectious Cycle in Vitro. Descamps, V., F. Helle, C. Louandre, E. Martin, E. Brochot, L. Izquierdo, C. Fournier, T.W. Hoffmann, S. Castelain, G. Duverlie, A. Galmiche, and C. Francois. Antiviral Research, 2015. 118: p. 93-102. PMID[25823619].
[PubMed]. OV_0522-060415.
4. Limonium sinense and Gallic acid Suppress Hepatitis C Virus Infection by Blocking Early Viral Entry. Hsu, W.C., S.P. Chang, L.C. Lin, C.L. Li, C.D. Richardson, C.C. Lin, and L.T. Lin. Antiviral Research, 2015. 118: p. 139-147. PMID[25865056].
[PubMed]. OV_0522-060415.
Citations from the ISI Web of Knowledge Listings for O.V.
5. Pyridine Hydroxamic acids Are Specific anti-HCV Agents Affecting HDAC6. Kozlov, M.V., A.A. Kleymenova, L.I. Romanova, K.A. Konduktorov, K.A. Kamarova, O.A. Smirnova, V.S. Prassolov, and S.N. Kochetkov. Bioorganic & Medicinal Chemistry Letters, 2015. 25(11): p. 2382-2385. ISI[000354115400023].
[WOS]. OV_0522-060415.